Speciality: Oncology
Description:
A warm welcome to all the medical professionals in this insightful session on understanding the Evolution in Treatment and Diagnosis of Lung Cancer. Manipal Hospitals, a leader in advanced medical care, is proud to present this initiative led by the esteemed Dr. Lalit Sharma. From conventional approaches to groundbreaking targeted therapies and immunotherapies, lung cancer treatment has undergone a significant transformation, offering renewed hope and improved outcomes for patients worldwide. This session aims to delve into these pivotal advancements, highlighting how a comprehensive understanding of evolving diagnostic tools and therapeutic strategies is paramount for delivering personalized and effective patient care.
The landscape of lung cancer management has been revolutionized by innovations in both diagnosis and treatment. Early detection, often facilitated by advanced imaging and novel biopsy techniques, now paves the way for more precise staging and tailored interventions. Furthermore, the advent of molecular profiling, including Next-Generation Sequencing (NGS), allows healthcare providers to identify specific genetic mutations within tumors, such as EGFR, ALK, ROS1, and BRAF. This precision medicine approach enables the selection of targeted therapies that directly address the underlying drivers of cancer, significantly enhancing efficacy and minimizing side effects compared to traditional chemotherapy.
Join us to gain comprehensive knowledge on the latest best practices in the evolution of lung cancer treatment and diagnosis. Dr. Lalit Sharma will share invaluable insights on navigating this rapidly advancing field, empowering medical professionals with the knowledge to optimize patient care and improve survival rates. Listen to this essential webinar, absorb the shared expertise, and continue to follow Hidoc for more such enriching educational sessions designed to keep you at the forefront of medical innovation.
See More Webinars @ Hidoc Webinars
1.
Doctors say lung cancer is still the deadliest cancer, but hope is growing
2.
Child Death Rates Are Rising in the U. s. ; Water Beads Warning; Cancer Studies Retracted.
3.
FDA Leaders Explain Their Choice Regarding Cancer Risk Warning in CAR-T Investigation.
4.
The FDA has approved momelotinib for use in myelofibrosis patients who also have anemia.
5.
Virtual Reality Travel Reduces Cancer Pain.
1.
Clinical Decision-Making in Oligometastatic Cancer: A Case-Based Perspective
2.
Iron Homeostasis Throughout the Female Lifespan
3.
The Benefits and Side Effects of Vidaza Syndrome
4.
Holistic Oncology: Advancing Survivorship, Nursing, and Innovative Cancer Care Models
5.
Exercise Rehabilitation in Hematologic Disease Survivorship
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients
2.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part V
3.
Efficient Management of First line ALK-rearranged NSCLC - Part IV
4.
A Continuation to The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma
5.
Preventing Blood Clots: The Importance of Venous Thromboembolism Management
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation